Literature DB >> 33709415

High spatial resolution spiral first-pass myocardial perfusion imaging with whole-heart coverage at 3 T.

Junyu Wang1, Yang Yang2,3, Daniel S Weller4, Ruixi Zhou1, Matthew Van Houten1, Changyu Sun1, Frederick H Epstein1,5, Craig H Meyer1,5, Christopher M Kramer3,5, Michael Salerno1,3,5.   

Abstract

PURPOSE: To develop and evaluate a high spatial resolution (1.25 × 1.25 mm2 ) spiral first-pass myocardial perfusion imaging technique with whole-heart coverage at 3T, to better assess transmural differences in perfusion between the endocardium and epicardium, to quantify the myocardial ischemic burden, and to improve the detection of obstructive coronary artery disease.
METHODS: Whole-heart high-resolution spiral perfusion pulse sequences and corresponding motion-compensated reconstruction techniques for both interleaved single-slice (SS) and simultaneous multi-slice (SMS) acquisition with or without outer-volume suppression (OVS) were developed. The proposed techniques were evaluated in 34 healthy volunteers and 8 patients (55 data sets). SS and SMS images were reconstructed using motion-compensated L1-SPIRiT and SMS-Slice-L1-SPIRiT, respectively. Images were blindly graded by 2 experienced cardiologists on a 5-point scale (5, excellent; 1, poor).
RESULTS: High-quality perfusion imaging was achieved for both SS and SMS acquisitions with or without OVS. The SS technique without OVS had the highest scores (4.5 [4, 5]), which were greater than scores for SS with OVS (3.5 [3.25, 3.75], P < .05), MB = 2 without OVS (3.75 [3.25, 4], P < .05), and MB = 2 with OVS (3.75 [2.75, 4], P < .05), but significantly higher than those for MB = 3 without OVS (4 [4, 4], P = .95). SMS image quality was improved using SMS-Slice-L1-SPIRiT as compared to SMS-L1-SPIRiT (P < .05 for both reviewers).
CONCLUSION: We demonstrated the successful implementation of whole-heart spiral perfusion imaging with high resolution at 3T. Good image quality was achieved, and the SS without OVS showed the best image quality. Evaluation in patients with expected ischemic heart disease is warranted.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  3 T; first-pass perfusion; high resolution; outer-volume; simultaneous multi-slice; spiral; suppression

Mesh:

Year:  2021        PMID: 33709415     DOI: 10.1002/mrm.28701

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  4 in total

Review 1.  Cardiac MR: From Theory to Practice.

Authors:  Tevfik F Ismail; Wendy Strugnell; Chiara Coletti; Maša Božić-Iven; Sebastian Weingärtner; Kerstin Hammernik; Teresa Correia; Thomas Küstner
Journal:  Front Cardiovasc Med       Date:  2022-03-03

2.  High-Resolution Free-Breathing Quantitative First-Pass Perfusion Cardiac MR Using Dual-Echo Dixon With Spatio-Temporal Acceleration.

Authors:  Joao Tourais; Cian M Scannell; Torben Schneider; Ebraham Alskaf; Richard Crawley; Filippo Bosio; Javier Sanchez-Gonzalez; Mariya Doneva; Christophe Schülke; Jakob Meineke; Jochen Keupp; Jouke Smink; Marcel Breeuwer; Amedeo Chiribiri; Markus Henningsson; Teresa Correia
Journal:  Front Cardiovasc Med       Date:  2022-04-29

3.  Simultaneous multislice steady-state free precession myocardial perfusion with full left ventricular coverage and high resolution at 1.5 T.

Authors:  Sarah McElroy; Giulio Ferrazzi; Muhummad Sohaib Nazir; Carl Evans; Joana Ferreira; Filippo Bosio; Nabila Mughal; Karl P Kunze; Radhouene Neji; Peter Speier; Daniel Stäb; Tevfik F Ismail; Pier Giorgio Masci; Adriana D M Villa; Reza Razavi; Amedeo Chiribiri; Sébastien Roujol
Journal:  Magn Reson Med       Date:  2022-03-28       Impact factor: 3.737

4.  A Slice-Low-Rank Plus Sparse (slice-L + S) Reconstruction Method for k-t Undersampled Multiband First-Pass Myocardial Perfusion MRI.

Authors:  Changyu Sun; Austin Robinson; Yu Wang; Kenneth C Bilchick; Christopher M Kramer; Daniel Weller; Michael Salerno; Frederick H Epstein
Journal:  Magn Reson Med       Date:  2022-05-24       Impact factor: 3.737

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.